GlassScriptPhysician profile
Michael W Zolman
NPI 1902942444
$13,665.14
in general payments reported to CMS, 2019-2025
19 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,663 · 2020: $336 · 2021: $465 · 2022: $619 · 2023: $6,230 · 2024: $2,512 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $242 · Entertainment: $120 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,121.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $241.67 |
| Entertainment | $120.45 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $8,268.82 | 2023-2025 | Optilight, M22 |
| Alcon Vision LLC | $1,920.14 | 2019-2024 | Total30, Precision 1 |
| Coopervision INC. | $1,400.60 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $451.06 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $315.07 | 2019-2025 | Acuvue |
| Mallinckrodt Hospital Products INC. | $302.72 | 2021-2023 | Acthar |
| Optos, INC. | $270.25 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Research LLC | $127.10 | 2019 | |
| Shire North American Group INC | $123.90 | 2019 | |
| Biotissue Holdings INC. | $121.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $89.93 | 2022-2023 | |
| Carl Zeiss Meditec USA, INC. | $62.06 | 2023 | Cirrus Hd-Oct |
| Maculogix, INC. | $51.83 | 2019 | |
| Lkc Technologies, INC. | $40.66 | 2025 | |
| Bausch & Lomb Americas INC. | $37.03 | 2022-2023 | Alrex, Vyzulta, Miebo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $27.44 | 2025 | |
| Oyster Point Pharma, INC. | $23.70 | 2024 | Tyrvaya |
| Allergan, INC. | $18.08 | 2020 | |
| Abbvie INC. | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zolman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.